Back to Journals » Psoriasis: Targets and Therapy » Call For Papers

Psoriasis: Targets and Therapy

ISSN: 2230-326X

The following Article Collection/ Thematic Series is currently open for submissions:

Life Style Interventions to Improve Outcome with Biologics

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Life Style Interventions to Improve Outcome with Biologics", organized by Guest Advisors Dr. Fabrizio Martora (University of Naples, Italy), Dr. Teresa Battista (University of Naples, Italy) and Dr. Matteo Megna (University of Naples, Italy) in Psoriasis: Targets and Therapy.

The management of psoriasis has evolved considerably over the past 100 years. This has occurred in parallel with our understanding of the pathogenesis of this common, complex and enigmatic disease. It should be celebrated as an outstanding example of successful translational research. With precise targeting of immune pathways for the treatment of psoriasis with new biologics and small molecules has come the realization that the most effective approach to patient management is a holistic one which encompasses the biopsychosocial nature of the disease. This involves a stratified medicine approach to identifying the best drug for an individual allied to patient education, screening for comorbidity, and regular review as both the clinical presentation and the patient's needs will change over time.

Extrinsic environmental factors, including patient lifestyle (alcohol intake, smoking, stress, sleep disturbances, and sedentary habit), diet and single nutrients intake may affect psoriasis clinical presentation, severity, and course.

Current authoritative knowledge confirms that low‐calories, Mediterranean, and protein restricted/vegetarian diets may be beneficial. Psoriatic patients are also recommended to engage regular physical activity, to avoid alcohol intake and to consume fish rich in omega‐3 polyunsaturated fatty acids, as well as fruit and vegetables. Prebiotics and probiotics may also provide potential benefit, whereas vitamin D supplementation and gluten‐free diet are useful in selected cases only. Changing of dietary and lifestyle habits alone does not replace conventional treatment but must be considered as an adjuvant.

Lifestyle and nutrition may play an important role in the outcome of psoriasis therefore, the purpose of our Article Collection should be a compilation of the authors' experiences of the interventions carried out to improve the outcome of the biological treatments available to date for psoriasis.

Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 24 March 2024.

Please submit your manuscript on our website, quoting the promo code OSZGU to indicate that your submission is for consideration in this Article Collection.

Please contact Haoyang Yi at [email protected] with any queries regarding this Article Collection.

View all papers in this article collection

Call For Papers

Editor-in-Chief: Dr Uwe Wollina

To see where Psoriasis: Targets and Therapy is indexed online view the Journal Metrics

What is the advantage to you of publishing in Psoriasis: Targets and Therapy?

  • It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
  • Unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
  • The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Psoriasis: Targets and Therapy has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
  • Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.

PubMed Central
Psoriasis: Targets and Therapy is indexed on PubMed Central (title abbreviation: Psoriasis (Auckl)). All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.

This journal will expedite the time in which research is published facilitating psoriatic thought.

Yours sincerely
Dr Uwe Wollina
Psoriasis: Targets and Therapy

Email: Editor-in-Chief